by Smith, D.A. et al.
However, these experiments also imply that tryptamine-derived hallucinogens might have a reduced potential for tolerance development, compared with phenethylamine-derived 5-HT2A agonists, and might therefore be more suitable for chronic administration in a therapeutic context.
J. Pharmacol. Exp. Ther. 2014; 3:485-91
